engage in life sciences

One Health

Indiana's Blueprint for Global Leadership

November 13, 2025 | Elanco Global Headquarters | Indianapolis

2025 BioCrossroads Life Sciences Summit

One Health: Advancing and Defining Indiana’s Leadership Opportunity

For more than two decades, the BioCrossroads Life Sciences Summit has served as a platform to elevate the people, organizations, and innovations driving Indiana’s life sciences sector forward. Each year, the Summit convenes more than 250 leaders from industry, academia, startups, policy, and the nonprofit sector for a focused day of dialogue around the most pressing challenges and emerging opportunities shaping the field.

The 2025 BioCrossroads Life Sciences Summit will put One Health at the center, recognizing that human, animal, plant, and environmental health are deeply interconnected, and that breakthroughs in one area can spark innovation across them all. With world-class R1 research universities, global industry leaders, and strong cross-sector partnerships, Indiana is uniquely positioned to define and deliver real-world One Health solutions.

 

What to Expect

Held in the heart of the emerging One Health Innovation District, this year’s Summit will bring together leaders from industry, academia, non-profits, and government for a full day of strategic dialogue. Conversations will focus on advancing sustainable farming, improving companion pet health, and reshoring critical supply chains — areas where Indiana’s strengths can make a global impact on public health and national security. 

These discussions will explore how Indiana can:

  • Align its strengths to address specific, high-impact One Health challenges

  • Advance public health, environmental resilience, and supply chain security

  • Accelerate the vision for the One Health Innovation District

  • Expand Indiana’s global leadership in life sciences

2024 Summit Recap

A Crucial Conversation Surrounding Indiana’s Impact on Global Health
 

The 2024 BioCrossroads Life Sciences Summit featured keynotes, panel discussions, and a patient roundtable focusing on the groundbreaking advancements in diabetes and obesity care management happening across Indiana’s life sciences ecosystem and impacting patients worldwide, including the development and potential for GLP-1’s.